Trazzo 100 mg belongs to the generic category of Trazodone Hydrochloride. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Trazzo 100 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Trazodone Hydrochloride and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

*Up to 10% Discount
(Depends on pharmacy)
/ Piece
Trazzo 100 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Trazzo 100 mg is provided below to help users gain a clear understanding of this medicine.
Trazzo 100 mg (Trazodone Hydrochloride) tablets are indicated for the treatment of major depressive disorder (MDD) in adults.
The mechanism of Trazzo 100 mg (Trazodone Hydrochloride)’s antidepressant action is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS. Trazodone is both a selective serotonin reuptake inhibitor (SSRI) and a 5HT2 receptor antagonist and the net result of this action on serotonergic transmission and its role in trazodone’s antidepressant effect is unknown.
An initial dose of 150 mg/day in divided doses is suggested. The dosage should be initiated at a low-dose and increased gradually, noting the clinical response and any evidence of intolerance. Occurrence of drowsiness may require the administration of a major portion of the daily dose at bedtime or a reduction of dosage. The dose may be increased by 50 mg/day every 3 to 4 days. The maximum dose for outpatients usually should not exceed 400 mg/day in divided doses. Inpatients (i.e., more severely depressed patients) may be given up to but not in excess of 600 mg/day in divided doses. Once an adequate response has been achieved, dosage may be gradually reduced, with subsequent adjustment depending on therapeutic response.
CNS Depressants: Trazzo 100 mg (Trazodone Hydrochloride) tablets may enhance effects of alcohol, barbiturates, or other CNS depressants. CYP3A4 Inhibitors: Consider Trazzo tablets dose reduction based on tolerability. CYP3A4 Inducers: Increase in Trazzo tablets dosage may be necessary. Digoxin or Phenytoin: Monitor for increased digoxin or phenytoin serum levels. Warfarin: Monitor for increased or decreased prothrombin time.
Most common adverse reactions (incidence ≥5% and twice that of placebo) are: edema, blurred vision, syncope, drowsiness, fatigue, diarrhea, nasal congestion, weight loss.
Serotonin Syndrome : Increased risk when co-administered with other serotonergic agents (e.g., SSRI, SNRI, triptans), but also when taken alone. If it occurs, discontinue Trazzo 100 mg (Trazodone Hydrochloride) tablets and initiate supportive treatment. Cardiac Arrhythmias : Increases the QT interval. Avoid use with drugs that also increase the QT interval and in patients with risk factors for prolonged QT interval. Orthostatic Hypotension and Syncope : Warn patients of risk and symptoms of hypotension. Increased Risk of Bleeding : Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other antiplatelet drugs, warfarin, and other anticoagulants may increase this risk. Priapism : Cases of painful and prolonged penile erections and priapism have been reported. Immediate medical attention should be sought if signs and symptoms of prolonged penile erections or priapism are observed. Activation of Mania or Hypomania : Screen for bipolar disorder and monitor for mania or hypomania. Potential for Cognitive and Motor Impairment : Has potential to impair judgment, thinking, and motor skills. Advise patients to use caution when operating machinery. Angle-Closure Glaucoma : Avoid use of antidepressants, including Trazzo tablets, in patients with untreated anatomically narrow angles.
Advise patients to notify their healthcare provider if they become pregnant or intend to become pregnant during therapy with Trazzo 100 mg (Trazodone Hydrochloride) tablets. Advise patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to trazodone hydrochloride tablets during pregnancy. Data from published literature report the transfer of trazodone into human milk. There are no data on the effect of trazodone on milk production. Limited data from postmarketing reports have not identified and association of adverse effects on the breastfed child. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for trazodone hydrochloride and any potential adverse effects on the breastfed child from trazodone hydrochloride or from the underlying maternal condition.
SSRIs & related anti-depressant drugs
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children. Pack Images: Trazzo 100 mg Tablet Thanks for using MedEx! How would you rate your experience so far?
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

N.B.: All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines.
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023